摘要
目的探讨联合用药治疗难治性支原体肺炎的临床疗效。方法 72例难治性支原体肺炎患儿均给予阿奇霉素,根据患儿合并感染的情况联合应用三代头孢抗生素,联合使用肾上腺糖皮质激素,对于症状严重者加用丙种球蛋白。结果经过2个疗程治疗后,72例患儿42例好转出院,30例患儿仍余肺部啰音未清,继续治疗1个疗程后,好转出院。随访2个月未见复发病例。结论早期联合用药治疗难治性支原体肺炎疗效确切,预后良好,值得临床推广和应用。
Objective To explore the combination treatmentrefractory mycoplasma pneumoniae pneumonia. Methods All 72 patients with refractory mycoplasma pneumonia with azithromycin are given, according to the children with infection of the combined application of the three generation cephalosporin antibiotic, or on the basis of the results of virus detection given antiviral therapy, combined with the use of corticosteroids, for serious symptoms combined with gamma globulin. Results After 2 courses of treatment, 72 cases, 42 cases had recovered, 30 cases still residual pulmonary rales not clear, to continue after 1 courses of treatment, improve leave hospital. A follow-up of 2 months showed no recurrence cases. Conclusion Early combination therapy in the treatment of refractory mycoplasma pneumonia curative effect is accurate, the prognosis is good, worthy of promotion and application.
出处
《中国医药指南》
2012年第20期438-439,共2页
Guide of China Medicine
关键词
难治性肺炎支原体肺炎
阿奇霉素
丙种球蛋白
Refractoriness mycoplasma pneumoniae pneumonia
Azithromyein
Gamma globulin
